Journal
JOURNAL OF MEDICAL GENETICS
Volume 55, Issue 10, Pages 701-704Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/jmedgenet-2017-104964
Keywords
diagnosis; gastroenterology; molecular genetics
Categories
Funding
- JSPS KAKENHI [17K15768]
- Grants-in-Aid for Scientific Research [17K15768, 17KT0124, 17K09004, 15K08611] Funding Source: KAKEN
Ask authors/readers for more resources
Background A genetic diagnosis has been rarely performed in benign familial hyperphosphatasaemia, and molecular mechanism largely remains unclear. Objectives We encountered a case with benign familial hyperphosphatasaemia of intestinal alkaline phosphatase (IAP). To elucidate the molecular mechanism, we performed ALPI gene sequencing and in vitro protein expression analysis. Methods ALPI gene was sequenced by long-range PCR and massively parallel sequencing. The soluble and membrane-bound ALP activities of the cultured cell line, transfected with the wild-type or variant-type ALPI gene were analysed by a glycosylphosphatidylinositol (GPI)-cleaving assay. Results We identified a deletion-insertion variant in the C-terminal end of the ALPI gene. This variant causes the attenuation of the hydrophobicity in GPI-anchor signal of IAP. An in vitro GPI-cleaving assay demonstrated that the membrane-bound IAP was greatly decreased, whereas the soluble IAP was increased, in the variant IAP. Conclusions The C-terminal variant in ALPI causes the benign familial hyperphosphatasaemia of IAP by the attenuation of the membrane-binding capability.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available